2), suggesting its cytotoxicity as previously observed (Fig
But as of today, Glucagon-Like peptide 1 receptor agonists (GLP1-RAs), sodium-glucose cotransporter 2 inhibitors (SGLT2is), dipeptidyl peptidase 4 inhibitors (DPP4is) and mineralocorticoid receptor antagonists, are quickly becoming part of, if not the drugs of choice for diabetes, especially in cases with heart, kidney or liver comorbidities [9,10,11,12]
The Influence of GLP-1 on Glucose-Stimulated Insulin Secretion: Effects on -Cell Sensitivity in Type 2 and Nondiabetic Subjects
Week 1-2: 0.5mg to 1mg once daily Week 3-4: 1mg once daily Week 5 onward: 1mg to 1.5mg once daily This gradual approach lets researchers assess tolerance
Unlike IV infusions or IM shots, with subcutaneous injections patients boost their glutathione and/or NAD levels from the comfort of their home
This helps your body make more oestrogen